Complementary equity research reports on D.N.A. Biomedical Solutions Ltd.

Report Type                              Publish Date                          Link

Initiation – English                     10 October 2017                  DNA_Biomedical.pdf

Initiation – Hebrew Appendix     10 October 2017                  DNA_Biomedical_Hebrew_Appendix.pdf

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success.

Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success.

Share This